[HTML][HTML] Update on the applications and limitations of alpha-fetoprotein for hepatocellular carcinoma

H Hanif, MJ Ali, AT Susheela, IW Khan… - World Journal of …, 2022 - ncbi.nlm.nih.gov
Alpha-fetoprotein (AFP) is an oncofetal glycoprotein that has been used as a tumor marker
for hepatocellular carcinoma (HCC) in combination with ultrasound and other imaging …

New blood biomarkers for the diagnosis of AFP-negative hepatocellular carcinoma

T Wang, KH Zhang - Frontiers in Oncology, 2020 - frontiersin.org
An early diagnosis of hepatocellular carcinoma (HCC) followed by effective treatment is
currently critical for improving the prognosis and reducing the associated economic burden …

EASL–EORTC clinical practice guidelines: management of hepatocellular carcinoma

European Association For The Study Of … - Journal of …, 2012 - journal-of-hepatology.eu
EASL–EORTC Clinical Practice Guidelines (CPG) on the management of hepatocellular
carcinoma (HCC) define the use of surveillance, diagnosis, and therapeutic strategies …

[HTML][HTML] EASL–EORTC clinical practice guidelines: management of hepatocellular carcinoma

EO for Research… - Journal of …, 2012 - Elsevier
EASL–EORTC Clinical Practice Guidelines (CPG) on the management of hepatocellular
carcinoma (HCC) define the use of surveillance, diagnosis, and therapeutic strategies …

[图书][B] Guidelines for the prevention care and treatment of persons with chronic hepatitis B infection: Mar-15

World Health Organization - 2015 - books.google.com
These are the first World Health Organization (WHO) guidelines for the prevention care and
treatment of persons living with CHB infection and complement similar recent published …

Evidence-based clinical guidelines for immigrants and refugees

K Pottie, C Greenaway, J Feightner, V Welch… - Cmaj, 2011 - Can Med Assoc
Health: Deborah Assayag, Elizabeth Barnett, Jennifer Blake, Beverly Brockest, Giovani
Burgos, Glenn Campbell, Andrea Chambers, Angie Chan, Maryann Cheetham, Walter …

Application of surveillance programs for hepatocellular carcinoma in the Asia–Pacific Region

D Amarapurkar, KH Han, HLY Chan… - Journal of …, 2009 - Wiley Online Library
Hepatocellular carcinoma (HCC) is a potential target for cancer surveillance (or screening)
as it occurs in well‐defined, at‐risk populations and curative therapy is possible only for …

Enhanced liver fibrosis test can predict clinical outcomes in patients with chronic liver disease

J Parkes, P Roderick, S Harris, C Day, D Mutimer… - Gut, 2010 - gut.bmj.com
Background Clinicians use fibrosis in a liver biopsy to predict clinical outcomes of chronic
liver disease. The performance of non-invasive tests has been evaluated against …

Cost-comparison analysis of FIB-4, ELF and fibroscan in community pathways for non-alcoholic fatty liver disease

A Srivastava, S Jong, A Gola, R Gailer, S Morgan… - BMC …, 2019 - Springer
Background The identification of patients with advanced liver fibrosis secondary to non-
alcoholic fatty liver disease (NAFLD) remains challenging. Using non-invasive liver fibrosis …

Cost-effectiveness of non-invasive methods for assessment and monitoring of liver fibrosis and cirrhosis in patients with chronic liver disease: systematic review and …

C Crossan, EA Tsochatzis, L Longworth, K Gurusamy… - 2015 - bura.brunel.ac.uk
BACKGROUND: Liver biopsy is the reference standard for diagnosing the extent of fibrosis
in chronic liver disease; however, it is invasive, with the potential for serious complications …